Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-03-28Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-03-12A Regulatory Required Non-interventional Study to Monitor the Safety and Effectiveness of Ofev(Nintedanib 150mg/100mg BID) in Korean Patients
-
CLINICAL_TRIALS study record update · 2024-02-28The European IPF Registry - an Internet-based, Pan-European Registry Linked to the European IPF Biobank (eurIPFbank)
-
CLINICAL_TRIALS study record update · 2024-02-20A Phase I Open Label, Dose Escalation Study to Characterize the Safety, Tolerability, and Efficacy of VUM02 Injection in Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-01-29Investigation of the Effectiveness of Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-01-16Telenursing With or Without Remote Monitoring Compared to Usual Care for Patients Newly Diagnosed With Idiopathic Pulmonary Fibrosis.
-
CLINICAL_TRIALS study record update · 2024-01-12Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis: The Relationship With Exercise Capacity, Physical Activity Level, and Quality of Life
-
CLINICAL_TRIALS study record update · 2024-01-10Effects of Home-based Inspiratory Muscle Training in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-01-05Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
-
CLINICAL_TRIALS study record update · 2023-12-22Early Diagnosis of Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2023-12-22Pulmonary Fibrosis Biomarker Cohort (PFBIO)
-
CLINICAL_TRIALS study record update · 2023-12-22Pulmonary Fibrosis Biomarkers During Exacerbation
-
CLINICAL_TRIALS study record update · 2023-12-15A Phase 1, Single-Center, Fixed Sequence, Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2023-12-12A Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF
-
CLINICAL_TRIALS study record update · 2023-12-11A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2023-11-28Idiopathic Pulmonary Fibrosis and Serum Bank
-
CLINICAL_TRIALS study record update · 2023-11-28The Assessment of Intelligent Oxygen Therapy (iO2t) in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2023-11-18A Single-center, Open Label Study to Evaluate the Safety，Tolerability and Pharmacokinetics of Multiple Administration of Sufenidone (SC1011) Tablets in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2023-11-18A Randomised, Double-blind, Placebo-controlled, SAD/MAD First-in-human, Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RXC007 Including Evaluation of Drug-Drug Interaction and Food Effect in Male Participants
-
CLINICAL_TRIALS study record update · 2023-11-18The Families-At-risk for Interstitial Lung Disease Study
-
CLINICAL_TRIALS study record update · 2023-11-02A Phase II, Multi-center, Randomized, Double-blinded, Placebo-controlled Clinical Study Evaluating the Efficacy and Safety of TDI01 Suspension for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2023-10-23TRK-250 - A Phase I, Double-Blind, Placebo-Controlled, Single and Multiple Inhaled Dose, Safety, Tolerability, and Pharmacokinetic Study of TRK-250 in Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2023-09-15Development of Airway Absorption Sampling Methods for Biomarker Assessment in Probable Idiopathic Pulmonary Fibrosis (IPF) Patients
-
CLINICAL_TRIALS study record update · 2023-09-07Differences in Heart Rate Variability and Nocturnal Blood Oxygen Saturation of Patients With Idiopathic Pulmonary Fibrosis Between at Baseline and During Acute Exacerbation
-
CLINICAL_TRIALS study record update · 2023-09-06Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis